You are here

Amgen

Drugmakers take sides in Amgen, Regeneron fight over antibody patents

BioPharma Dive

Mon, 04/24/23 - 10:17 am

Regeneron Pharmaceuticals

Finding the big spenders beyond big pharma

EP Vantage

Mon, 04/24/23 - 10:15 am

Gilead Sciences

Moderna Therapeutics

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

Big pharma holds steady on research spending

EP Vantage

Fri, 04/21/23 - 10:03 am

Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028

Fierce Pharma

Thu, 04/20/23 - 11:47 am

AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'

Fierce Biotech

Tue, 04/18/23 - 10:18 pm

Mirati Therapeutics

KRAS inhibitors

Biotech layoffs gather pace as industry downturn persists

BioPharma Dive

Tue, 04/11/23 - 07:18 pm

Jounce Therapeutics

Fate Therapeutics

Molecular Templates

Sorrento Therapeutics

After 2022's M&A spree, Amgen CEO Bradway collects $21.4M payday

Fierce Pharma

Mon, 04/10/23 - 05:06 pm

executive compensation

Amgen's denosumab shows promise in small, NIH-funded rare bone disease study

Endpoints

Wed, 04/5/23 - 07:15 pm

clinical trials

monoclonal antibodies

Acquired patents aid J&J defense of top-selling drug from biosimilar challenge

BioPharma Dive

Wed, 03/29/23 - 03:56 pm

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

Amgen cites inflation, pressure on drug prices in 450-person layoff

Endpoints

Fri, 03/17/23 - 09:59 am

Amgen is sued for concealing $10.7 billion tax bill from investors

Reuters

Wed, 03/15/23 - 11:11 am

Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med

Fierce Biotech

Tue, 03/7/23 - 11:45 am

Volastra Therapeutics

Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim

Fierce Pharma

Fri, 03/3/23 - 11:56 am

Could This Humira Biosimilar Be a Winner for Amgen?

Motley Fool

Fri, 03/3/23 - 11:48 am

Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market

Fierce Biotech

Tue, 02/28/23 - 10:03 am

Junshi Biosciences

clinical trials

PCSK9 inhibitors

Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US

Pharmaceutical Business Review

Fri, 02/17/23 - 09:44 am

Years after the first US biosim launches, doctors still have their concerns: survey

Fierce Pharma

Thu, 02/16/23 - 04:49 pm

Amgen bond offering to help fund Horizon Therapeutics acquisition

Seeking Alpha

Thu, 02/16/23 - 11:26 am

Horizon Therapeutics

BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff

BioSpace

Thu, 02/16/23 - 11:18 am

Frequency Therapeutics

Eliem Therapeutics

Aligos Therapeutics

Thermo Fisher Scientific

Magenta Therapeutics

Y-mAbs Therapeutics

Century Therapeutics

Elevation Oncology

Calithera Biosciences

Editas Medicine

Pages